![[.jpg] quanta-automatic-pen-injector](https://cdn.bfldr.com/DTG6CG68/at/b69b79hv3skbp78nn663prjv/quanta-automatic-pen-injector.jpg?width=480&height=480&fit=crop&auto=webp&format=webp)
Automatic injection
Spring-assisted mechanism for controlled delivery
Quanta
An automatic, multi-fixed-dose pen built for once-weekly cardiometabolic therapies. Its no-priming design and spring-driven injection support smooth operation at each activation.
![[.png] hero-top-banner-quanta-pen-injector](https://cdn.bfldr.com/DTG6CG68/at/m6xnrkfcvxctm8xvh6bgff33/hero-top-banner-quanta-pen-injector.png?width=320&height=375&fit=cover&auto=webp&format=webp)
A simpler way to manage weekly doses
Specifically developed for once-weekly cardiometabolic needs, Quanta introduces intentional design features in a pen injector format to streamline weekly administration.
![[.jpg] quanta-pen-injector-no-priming](https://cdn.bfldr.com/DTG6CG68/at/nfgh9z5c3g6vghg5cr8g739t/quanta-pen-injector-no-priming.jpg?width=480&height=480&fit=crop&auto=webp&format=webp)
No-priming design
Helps reduce handling steps
![[.jpg] quanta-fixed-dose-pen-injector](https://cdn.bfldr.com/DTG6CG68/at/nz7nk26hmkqfgspxfq767n/quanta-fixed-dose-pen-injector.jpg?width=480&height=480&fit=crop&auto=webp&format=webp)
Fixed dose
Same dose per injection
![[.jpg] <p>quanta-multiple-dose-pen-injector</p>](https://cdn.bfldr.com/DTG6CG68/at/rcgvj9svsrk9pgn6csx8s4/quanta-multiple-dose-pen-injector.jpg?width=480&height=480&fit=crop&auto=webp&format=webp)
Multiple dose
Supports 4-6 doses per device
Performance that repeats
Quanta pen injector focuses on four key areas central to long-duration therapy programs: handling experience, dosing performance, cost considerations, and sustainability alignment.
Enhanced user experience
Quanta integrates automatic, spring-driven mechanism and a no-priming design to minimize preparatory steps. Built-in indicators guide the injection sequence, supporting a straightforward operation.
![[.jpg] enhanced-user-experience](https://cdn.bfldr.com/DTG6CG68/at/rsx4jpjkx7mp57rf6wx75r9t/enhanced-user-experience.jpg?width=384&height=384&fit=crop&auto=webp&format=webp)
Fixed-dose confidence
Quanta’s fixed-dose format removes dose-selection choices and provides a consistent cadence for each injection. This setup reduces variability in user operation and helps users navigate repeated administration with ease.
![[.jpg] reliable-dosing-performance](https://cdn.bfldr.com/DTG6CG68/at/kj8z4wsx9v8jc6mpnx5jv7wz/reliable-dosing-performance.jpg?width=384&height=384&fit=crop&auto=webp&format=webp)
Operational cost efficiency
Quanta’s multi-dose configuration reduces the number of devices required per dosing cycle. This enables more efficient inventory management, streamlined distribution, and cost-effective operations for growing patient populations.
![[.jpg] <p>operational-cost-efficiency</p>](https://cdn.bfldr.com/DTG6CG68/at/74kmfmjkpcct5qvvfcm4x9w6/operational-cost-efficiency.jpg?width=384&height=384&fit=crop&auto=webp&format=webp)
Sustainability considerations
Compared with a single use autoinjector, Quanta helps reduce total materials used and carbon footprint over the course of treatment. Its design supports circularity through the use of certified bio-circular plastics and efficient packaging and logistics.
![[.jpg] sustainability-considerations](https://cdn.bfldr.com/DTG6CG68/at/mpgp3spw5v9ff3p5jmtw9m3t/sustainability-considerations.jpg?width=384&height=384&fit=crop&auto=webp&format=webp)
Global manufacturing built for scale
SHL Medical operates a vertically integrated manufacturing network, designed to support scalable production of innovative self-injection devices, such as autoinjectors and pen injectors. Through in-house molding, integrated testing, and automated assembly, we maintain oversight of key steps that influence device quality and continuity of supply.
Our modular manufacturing infrastructure supports transition from clinical to commercial production while reducing transfer needs. With multi-site capacity and established supply frameworks, we support device availability as patient volumes grow.
![[.jpg] global-manufacturing-built-scale](https://cdn.bfldr.com/DTG6CG68/at/q32bsm95gv8q5cknhnt9rw/global-manufacturing-built-scale.jpg?width=480&auto=webp&format=webp)
Specifications
- Viscosity
- Low
- Device type
- Automatic, multi-dose pen injector
- Primary container
- 1.5 mL and 3.0 mL RTU cartridges
- Dose type
- Multi-fixed-dose | 4-6 doses
- Dose volume
- Up to 0.75 mL
- Viscosity
- Low
- Route of administration
- Subcutaneous
- Activation method
- Spring-assisted button
- Injection feedback
- Audible click at beginning and near end of injection, viewing window, dose indicator
- Customization
- Yes
Related resources
Webcast: Cardiometabolic therapies at scale and their implications for drug delivery
Get in touch
Connect with us to explore how Quanta pen injector can align with your program’s delivery requirements, timelines, and development path.
Other solutions
Molly 1.0
Viscosity
Volume
Molly 1.0 is a 2-step autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines.
Molly 2.25
Viscosity
Volume
Molly 2.25 is a large-volume variant of the Molly autoinjector, developed to support the delivery of larger-volume biologics with the same 2-step operation.